ArticleCancer biomarkers : section A of Disease markers2016

KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer.

Karen Bento Ribeiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.